Professor Ahmed Ahmed
MBBCH, MSc, MD, MRCOG, PhD
Professor of Gynaecological Oncology
- Consultant Gynaecological Oncology Surgeon
- Director of the Ovarian Cancer Cell Laboratory at the Weatherall Institute of Molecular Medicine
"Paclitaxel Sensitivity of Ovarian Cancer can be enhanced by knocking down Pairs of Kinases that regulate MAP4 Phosphorylation and Microtubule Stability"
"Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation"
Our group is interested in investigating the mechanistic basis of ovarian cancer development, progression and resistance to therapy. We are interested in understanding the key initiating factors that determine how precursor cells develop into tumours and how such tumours evolve under therapeutic selection. Our aim is to translate such understanding into early detection methods for women who are at high risk of ovarian cancer and to develop novel therapeutic approaches to prevent recurrence of ovarian cancers following primary treatment. We combine novel surgical techniques in prospective clinical trials with mechanistic laboratory investigations to achieve our goals.
I am a Professor of Gynaecological Oncology at the Nuffield Department of Women's & Reproductive Health at the University of Oxford and a Consultant Gynaecological Oncology Surgeon at the Oxford Cancer and Haematology Centre and is a Fellow of St Hugh’s College. I lead laboratory-based translational research in Gynaecological Oncology. My main research interest is in the surgical, medical and fundamental research into ovarian cancer. I graduated from Ain Shams University in Cairo, Egypt and completed my PhD and Gynaecological Oncology Surgical training at the University of Cambridge. I received my postdoctoral research training at the University of Cambridge and at the University of Texas, M.D. Anderson Cancer Centre in the USA. I was appointed as a Clinical Reader in Oxford in 2010 and became a Medical Research Council Senior Clinical Research Fellow at the Weatherall Institute of Molecular Medicine and Professor of Gynaecological Oncology in 2012.